O	0	6	Effect
O	7	9	of
B-intervention	10	11	β
I-intervention	11	12	-
I-intervention	12	18	glucan
O	19	21	on
B-condition	22	27	drain
I-condition	28	33	fluid
I-condition	34	37	and
I-condition	38	44	amount
I-condition	45	47	of
I-condition	48	56	drainage
O	57	66	following
O	67	75	modified
O	76	83	radical
O	84	94	mastectomy
O	94	95	.

O	96	98	To
O	99	105	reduce
O	106	109	the
O	110	116	seroma
O	117	126	formation
O	127	136	following
O	137	147	mastectomy
O	148	151	and
O	152	160	axillary
O	161	171	dissection
O	171	172	,
O	173	177	many
O	178	187	different
O	188	198	techniques
O	199	202	and
O	203	208	drugs
O	209	213	have
O	214	218	been
O	219	231	investigated
O	231	232	.

O	233	236	The
O	237	240	aim
O	241	243	of
O	244	248	this
O	249	254	study
O	255	257	is
O	258	260	to
O	261	269	evaluate
O	270	273	the
O	274	281	effects
O	282	284	of
O	285	289	oral
O	290	291	β
O	291	292	-
O	292	298	glucan
O	299	301	on
O	302	307	drain
O	308	313	fluid
O	314	317	and
O	318	326	efficacy
O	327	329	of
O	330	335	daily
O	336	344	drainage
O	345	348	and
O	349	354	drain
O	355	362	removal
O	363	366	day
O	367	369	in
O	370	380	mastectomy
O	381	389	patients
O	389	390	.

B-total-participants	391	394	One
I-total-participants	395	402	hundred
I-total-participants	403	406	and
I-total-participants	407	413	thirty
O	414	420	breast
O	421	427	cancer
O	428	436	patients
O	437	439	of
O	440	446	Ankara
O	447	455	Oncology
O	456	464	Training
O	465	468	and
O	469	477	Research
O	478	486	Hospital
O	487	491	were
O	492	499	divided
O	500	504	into
O	505	506	2
O	507	513	groups
O	514	516	by
O	517	528	consecutive
O	529	542	randomization
O	543	544	(
O	544	545	n
O	546	547	=
B-intervention-participants	548	550	65
O	551	555	each
O	555	556	)
O	556	557	.

O	558	559	β
O	559	560	-
O	560	566	glucan
O	567	569	10
O	570	572	mg
O	573	581	capsules
O	582	586	were
O	587	599	administered
O	600	602	to
O	603	608	Group
O	609	610	1
O	611	616	twice
O	617	618	a
O	619	622	day
O	623	626	for
O	627	629	10
O	630	634	days
O	634	635	.

O	636	641	Group
O	642	643	2
O	644	648	took
B-control	649	657	placebos
O	658	660	in
O	661	664	the
O	665	669	same
O	670	676	manner
O	676	677	.

O	678	681	Age
O	681	682	,
O	683	691	menarche
O	692	695	age
O	695	696	,
O	697	706	menopause
O	706	707	,
O	708	714	parity
O	714	715	,
O	716	723	history
O	724	726	of
O	727	731	oral
O	732	746	contraceptives
O	746	747	,
O	748	761	comorbidities
O	761	762	,
O	763	776	postoperative
O	777	782	daily
O	783	791	drainage
O	792	799	volumes
O	800	803	and
O	804	809	drain
O	810	817	removal
O	818	822	days
O	823	827	were
O	828	836	recorded
O	837	840	and
O	841	849	compared
O	849	850	.

O	851	857	Seroma
O	858	865	samples
O	866	872	during
O	873	876	the
O	877	882	first
O	883	886	and
O	887	893	second
O	894	897	day
O	898	900	of
O	901	909	drainage
O	910	914	were
O	915	920	taken
O	921	924	for
O	925	933	analysis
O	934	936	of
O	937	948	Interleukin
O	948	949	-
O	949	950	6
O	951	952	(
O	952	954	IL
O	954	955	-
O	955	956	6
O	956	957	)
O	958	961	and
O	962	967	Tumor
O	968	976	Necrosis
O	977	983	Factor
O	984	985	(
O	985	988	TNF
O	988	989	-
O	989	990	α
O	990	991	)
O	991	992	.

O	993	998	There
O	999	1002	was
O	1003	1005	no
O	1006	1016	difference
O	1017	1024	between
O	1025	1031	groups
O	1032	1034	in
O	1035	1040	terms
O	1041	1043	of
O	1044	1047	age
O	1047	1048	,
O	1049	1057	menarche
O	1058	1061	age
O	1061	1062	,
O	1063	1072	menopause
O	1073	1079	period
O	1079	1080	,
O	1081	1087	parity
O	1087	1088	,
O	1089	1093	oral
O	1094	1107	contraceptive
O	1108	1111	use
O	1112	1115	and
O	1116	1129	comorbidities
O	1129	1130	.

O	1131	1136	Group
O	1137	1138	1
O	1139	1145	showed
O	1146	1159	significantly
O	1160	1165	lower
B-outcome	1166	1171	daily
I-outcome	1172	1180	drainage
I-outcome	1181	1188	volumes
O	1189	1196	between
O	1197	1201	days
O	1202	1203	2
O	1204	1207	and
O	1208	1209	8
O	1209	1210	.

B-outcome	1211	1215	Mean
I-outcome	1216	1221	drain
I-outcome	1222	1229	removal
I-outcome	1230	1233	day
O	1234	1237	was
B-iv-cont-mean	1238	1239	7
I-iv-cont-mean	1239	1240	.
I-iv-cont-mean	1240	1242	16
O	1243	1244	±
B-iv-cont-sd	1245	1246	1
I-iv-cont-sd	1246	1247	.
I-iv-cont-sd	1247	1249	72
O	1250	1252	in
O	1253	1258	Group
O	1259	1260	1
O	1261	1264	and
B-cv-cont-mean	1265	1266	8
I-cv-cont-mean	1266	1267	.
I-cv-cont-mean	1267	1269	59
O	1270	1271	±
B-cv-cont-sd	1272	1273	2
I-cv-cont-sd	1273	1274	.
I-cv-cont-sd	1274	1276	27
O	1277	1279	in
O	1280	1285	Group
O	1286	1287	2
O	1287	1288	.

O	1289	1292	The
O	1293	1303	difference
O	1304	1307	was
O	1308	1319	significant
O	1320	1321	(
O	1321	1322	p
O	1323	1324	<
O	1325	1326	0
O	1326	1327	.
O	1327	1330	001
O	1330	1331	)
O	1331	1332	.

B-outcome	1333	1336	TNF
I-outcome	1336	1337	-
I-outcome	1337	1338	α
I-outcome	1339	1342	and
I-outcome	1343	1345	IL
I-outcome	1345	1346	-
I-outcome	1346	1347	6
I-outcome	1348	1354	levels
O	1355	1357	on
O	1358	1362	days
O	1363	1364	1
O	1365	1368	and
O	1369	1370	2
O	1371	1373	in
O	1374	1379	Group
O	1380	1381	1
O	1382	1386	were
O	1387	1400	significantly
O	1401	1406	lower
O	1407	1408	(
O	1408	1409	p
O	1410	1411	<
O	1412	1413	0
O	1413	1414	.
O	1414	1417	001
O	1417	1418	)
O	1418	1419	.

O	1420	1422	In
O	1423	1431	addition
O	1431	1432	,
O	1433	1434	β
O	1434	1435	-
O	1435	1441	glucan
O	1442	1455	significantly
O	1456	1465	shortened
O	1466	1469	the
B-outcome	1470	1476	number
I-outcome	1477	1479	of
I-outcome	1480	1484	days
I-outcome	1485	1493	required
I-outcome	1494	1497	for
I-outcome	1498	1501	the
I-outcome	1502	1507	drain
I-outcome	1508	1515	removal
O	1516	1518	in
O	1519	1527	patients
O	1528	1531	who
O	1532	1536	have
O	1537	1550	comorbidities
O	1551	1552	(
O	1552	1553	p
O	1554	1555	=
O	1556	1557	0
O	1557	1558	.
O	1558	1561	018
O	1561	1562	)
O	1562	1563	.

O	1564	1567	The
O	1568	1576	earliest
O	1577	1584	removal
O	1585	1588	was
O	1589	1591	in
O	1592	1600	patients
O	1601	1608	without
O	1609	1620	comorbidity
O	1621	1624	and
O	1625	1628	who
O	1629	1637	received
O	1638	1639	β
O	1639	1640	-
O	1640	1646	glucan
O	1647	1648	(
O	1648	1649	p
O	1650	1651	=
O	1652	1653	0
O	1653	1654	.
O	1654	1657	002
O	1657	1658	)
O	1658	1659	.

O	1660	1661	β
O	1661	1662	-
O	1662	1668	glucan
O	1669	1678	decreased
O	1679	1684	drain
O	1685	1695	discharges
O	1696	1701	after
O	1702	1712	mastectomy
O	1712	1713	.

O	1714	1717	The
O	1718	1724	drains
O	1725	1729	were
O	1730	1737	removed
O	1738	1745	earlier
O	1746	1748	in
O	1749	1750	β
O	1750	1751	-
O	1751	1757	glucan
O	1758	1770	administered
O	1771	1779	patients
O	1779	1780	.
